Sangamo Therapeutics
(NASDAQ) SGMO
Sangamo Therapeutics Financials at a Glance
Market Cap
$104.07M
Revenue (TTM)
$39.55M
Net Income (TTM)
$122.93M
EPS (TTM)
$-0.44
P/E Ratio
-0.57
Dividend
$0.00
Beta (Volatility)
1.64 (High)
Dividend
$0.00
Beta (Volatility)
1.64 (High)
Price
$0.26
Volume
4,418,554
Open
$0.26
Price
$0.26
Volume
4,418,554
Open
$0.26
Previous Close
$0.25
Daily Range
$0.25 - $0.28
52-Week Range
$0.20 - $0.84
Dividend
$0.00
Beta (Volatility)
1.64 (High)
Price
$0.26
Volume
4,418,554
Open
$0.26
Previous Close
$0.25
Daily Range
$0.25 - $0.28
52-Week Range
$0.20 - $0.84
SGMO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sangamo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
142
CEO
Alexander D. Macrae, PhD
Website
www.sangamo.comHeadquarters
Richmond, CA 94005, US
SGMO Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-2892%
Return on Capital
-6%
Return on Assets
-2%
Earnings Yield
-1.75%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$104.07M
Shares Outstanding
414.27M
Volume
4.42M
Short Interest
0.00%
Avg. Volume
6.80M
Financials (TTM)
Gross Profit
$31.95M
Operating Income
$108.00M
EBITDA
$100.40M
Operating Cash Flow
$97.21M
Capital Expenditure
$102.00K
Free Cash Flow
$97.31M
Cash & ST Invst.
$20.95M
Total Debt
$26.80M
Sangamo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$14.23M
+88.4%
Gross Profit
$6.63M
-12.3%
Gross Margin
46.57%
N/A
Market Cap
$104.07M
N/A
Market Cap/Employee
$568.66K
N/A
Employees
183
N/A
Net Income
$37.42M
-59.9%
EBITDA
$23.09M
+3.2%
Quarterly Fundamentals
Net Cash
$5.85M
-151.5%
Accounts Receivable
$371.00K
-91.9%
Inventory
$0.00
N/A
Long Term Debt
$25.09M
-4.4%
Short Term Debt
$1.70M
-60.5%
Return on Assets
-2.06%
N/A
Return on Invested Capital
-6.25%
N/A
Free Cash Flow
$24.42M
-597.0%
Operating Cash Flow
$24.40M
-628.2%